Rockefeller Capital Management
BMY.RT

Rockefeller Capital Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Rockefeller Capital Management’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-27,724
Closed -$18K – 3478
2020
Q4 		$18K Sell
27,724
-840
-3% -$1.79K ﹤0.01% 2062
2020
Q3 		$63K Buy
28,564
+4,519
+19% +$12.9K ﹤0.01% 1432
2020
Q2 		$86K Sell
24,045
-574
-2% -$2.07K ﹤0.01% 1223
2020
Q1 		$93K Buy
24,619
+676
+3% +$2.23K ﹤0.01% 1037
2019
Q4 		$72K Buy
+23,943
New +$62.3K ﹤0.01% 1057

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Rockefeller Capital Management's BMY.RT Position: Q1 2021 in Review

Rockefeller Capital Management sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 27,724 shares — an estimated $18K sold.

Rockefeller Capital Management first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $93K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Rockefeller Capital Management reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Rockefeller Capital Management sold 27,724 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $18K.
  • Rockefeller Capital Management first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Rockefeller Capital Management's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $93K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Rockefeller Capital Management's 13F filing for Q1 2021, filed 11 May 2021.